Matches in Wikidata for { <http://www.wikidata.org/entity/Q99081902> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q99081902 description "clinical trial" @default.
- Q99081902 description "ensayo clínico" @default.
- Q99081902 description "ensayu clínicu" @default.
- Q99081902 description "klinisch onderzoek" @default.
- Q99081902 description "клінічне випробування" @default.
- Q99081902 description "կլինիկական փորձարկում" @default.
- Q99081902 description "临床试验" @default.
- Q99081902 name "DS-1062a in Combination With Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung02)" @default.
- Q99081902 name "DS-1062a in Combination With Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung02)" @default.
- Q99081902 type Item @default.
- Q99081902 label "DS-1062a in Combination With Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung02)" @default.
- Q99081902 label "DS-1062a in Combination With Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung02)" @default.
- Q99081902 prefLabel "DS-1062a in Combination With Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung02)" @default.
- Q99081902 prefLabel "DS-1062a in Combination With Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung02)" @default.
- Q99081902 P1132 Q99081902-737D2B0B-C6CB-45CF-90D6-08974073B1A4 @default.
- Q99081902 P1476 Q99081902-E5D2F176-A571-4AE9-A666-DE6269ADF5FB @default.
- Q99081902 P17 Q99081902-A17C6955-682D-4A8D-8BC5-B1C54BB1140A @default.
- Q99081902 P17 Q99081902-E4B71610-5A92-45F9-B93D-6B6A709AA41A @default.
- Q99081902 P2899 Q99081902-C96F1056-463C-4D41-9155-FBE0A0D406A1 @default.
- Q99081902 P3098 Q99081902-8C08D32D-E7EA-4164-9E52-A94DE33A03E6 @default.
- Q99081902 P31 Q99081902-A64AD479-F346-49CF-B6A1-E381512BA36F @default.
- Q99081902 P4844 Q99081902-993DCE18-0ED0-4C75-9717-7AC830ABD2BB @default.
- Q99081902 P580 Q99081902-F2E63733-BAEA-406C-B8ED-F0AF7A8C0627 @default.
- Q99081902 P582 Q99081902-EF76FEE2-2BCE-405E-A11B-49D168440550 @default.
- Q99081902 P6099 Q99081902-0015FD62-4F93-42EE-BDEB-A0B0FFE3FAB3 @default.
- Q99081902 P6153 Q99081902-39FF3EDB-D69F-4EE2-B21D-15E0DEB28C5C @default.
- Q99081902 P6153 Q99081902-4E4ECDEC-9875-4FAA-90FD-5EA6BDADF64A @default.
- Q99081902 P6153 Q99081902-F642DEED-8CE4-4252-B237-856FFA18511D @default.
- Q99081902 P767 Q99081902-DE4CDCC7-9803-47BE-87EE-2DAD9D140D9B @default.
- Q99081902 P8005 Q99081902-AC613CE6-4204-4B9B-9152-35B979DCCDFA @default.
- Q99081902 P8363 Q99081902-F4577B1B-688B-46EE-857B-0475A3A265E7 @default.
- Q99081902 P859 Q99081902-90D01E08-8579-45B2-B794-8741819B48A3 @default.
- Q99081902 P1132 "+86" @default.
- Q99081902 P1476 "Phase 1b, Multicenter, 2-part, Open-label Study of DS-1062a in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations and Previously Treated With Platinum-based Chemotherapy With or Without Prior Immunotherapy (TROPION-Lung02)" @default.
- Q99081902 P17 Q17 @default.
- Q99081902 P17 Q30 @default.
- Q99081902 P2899 "+18" @default.
- Q99081902 P3098 "NCT04526691" @default.
- Q99081902 P31 Q30612 @default.
- Q99081902 P4844 Q13896859 @default.
- Q99081902 P580 "2020-10-15T00:00:00Z" @default.
- Q99081902 P582 "2022-06-15T00:00:00Z" @default.
- Q99081902 P6099 Q5452194 @default.
- Q99081902 P6153 Q1130172 @default.
- Q99081902 P6153 Q193727 @default.
- Q99081902 P6153 Q55454195 @default.
- Q99081902 P767 Q58219685 @default.
- Q99081902 P8005 Q76649614 @default.
- Q99081902 P8363 Q78089383 @default.
- Q99081902 P859 Q669441 @default.